18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
above 19 24 19 24 O

Anticipated 0 11 25 36 O
surgery 12 19 37 44 B-treatment
during 20 26 45 51 O
the 27 30 52 55 O
study 31 36 56 61 O
period 37 43 62 68 O

Blood 0 5 69 74 O
donation 6 14 75 83 O
in 15 17 84 86 O
the 18 21 87 90 O
last 22 26 91 95 B-upper_bound
2 27 28 96 97 I-upper_bound
weeks 29 34 98 103 I-upper_bound
or 35 37 104 106 O
planned 38 45 107 114 O
blood 46 51 115 120 O
donation 52 60 121 129 O
during 61 67 130 136 O
the 68 71 137 140 O
study 72 77 141 146 O

History 0 7 147 154 O
of 8 10 155 157 O
prostate 11 19 158 166 B-cancer
Cancer 20 26 167 173 I-cancer

Known 0 5 174 179 O
sensitivity 6 17 180 191 O
or 18 20 192 194 O
allergy 21 28 195 202 O
to 29 31 203 205 O
fish 32 36 206 210 B-allergy_name
, 36 37 210 211 O
shellfish 38 47 212 221 B-allergy_name
or 48 50 222 224 O
omega-3 51 58 225 232 B-allergy_name
fatty 59 64 233 238 I-allergy_name
acids 65 70 239 244 I-allergy_name
supplements 71 82 245 256 I-allergy_name

Liver 0 5 257 262 O
enzymes 6 13 263 270 O
( 14 15 271 272 O
AST 15 18 272 275 B-clinical_variable
or 19 21 276 278 O
ALT 22 25 279 282 B-clinical_variable
) 25 26 282 283 O
levels 27 33 284 290 O
above 34 39 291 296 O
3x 40 42 297 299 B-lower_bound
upper 43 48 300 305 I-lower_bound
limit 49 54 306 311 I-lower_bound
of 55 57 312 314 I-lower_bound
normal 58 64 315 321 I-lower_bound

Male 0 4 322 326 B-gender
and 5 8 327 330 I-gender
female 9 15 331 337 I-gender
participants 16 28 338 350 I-gender

Pregnancy 0 9 351 360 B-pregnancy
, 9 10 360 361 O
planned 11 18 362 369 B-pregnancy
pregnancy 19 28 370 379 I-pregnancy
( 29 30 380 381 O
within 30 36 381 387 O
the 37 40 388 391 O
study 41 46 392 397 O
period 47 53 398 404 O
) 53 54 404 405 O
or 55 57 406 408 O
women 58 63 409 414 B-gender
currently 64 73 415 424 O
breastfeeding 74 87 425 438 O

Subject 0 7 439 446 O
must 8 12 447 451 O
be 13 15 452 454 O
healthy 16 23 455 462 O
, 23 24 462 463 O
with 25 29 464 468 O
no 30 32 469 471 O
known 33 38 472 477 O
history 39 46 478 485 O
of 47 49 486 488 O
cardiovascular 50 64 489 503 B-chronic_disease
disease 65 72 504 511 I-chronic_disease

Subjects 0 8 512 520 O
already 9 16 521 528 O
consuming 17 26 529 538 O
more 27 31 539 543 O
than 32 36 544 548 O
1.5 37 40 549 552 B-lower_bound
g 41 42 553 554 I-lower_bound
per 43 46 555 558 I-lower_bound
day 47 50 559 562 I-lower_bound
of 51 53 563 565 O
EPA 54 57 566 569 B-clinical_variable
/ 57 58 569 570 I-clinical_variable
DHA 58 61 570 573 I-clinical_variable
in 62 64 574 576 O
any 65 68 577 580 O
form 69 73 581 585 O

Subjects 0 8 586 594 O
being 9 14 595 600 O
treated 15 22 601 608 O
with 23 27 609 613 O
tamoxifen 28 37 614 623 B-treatment
, 37 38 623 624 O
estrogens 39 48 625 634 B-treatment
, 48 49 634 635 O
or 50 52 636 638 O
progestins 53 63 639 649 B-treatment
that 64 68 650 654 O
have 69 73 655 659 O
not 74 77 660 663 O
been 78 82 664 668 O
stable 83 89 669 675 O
for 90 93 676 679 O
> 94 95 680 681 O
4 95 96 681 682 B-lower_bound
weeks 97 102 683 688 I-lower_bound

Subjects 0 8 689 697 O
diagnosed 9 18 698 707 O
with 19 23 708 712 O
cancer 24 30 713 719 B-cancer
or 31 33 720 722 O
IBD 34 37 723 726 B-chronic_disease
, 37 38 726 727 O
or 39 41 728 730 O
that 42 46 731 735 O
have 47 51 736 740 O
taken 52 57 741 746 O
diarrhea 58 66 747 755 B-treatment
inhibitors 67 77 756 766 I-treatment
, 77 78 766 767 O
laxatives 79 88 768 777 B-treatment
or 89 91 778 780 O
prebiotics 92 102 781 791 B-treatment
in 103 105 792 794 O
the 106 109 795 798 O
week 110 114 799 803 O
before 115 121 804 810 O
stool 122 127 811 816 O
sampling 128 136 817 825 O
( 137 138 826 827 O
optional 138 146 827 835 O
) 146 147 835 836 O
, 147 148 836 837 O
or 149 151 838 840 O
antibiotics 152 163 841 852 B-treatment
within 164 170 853 859 O
3 171 172 860 861 B-upper_bound
months 173 179 862 868 I-upper_bound
before 180 186 869 875 I-upper_bound
sampling 187 195 876 884 O

Subjects 0 8 885 893 O
initiating 9 19 894 904 O
new 20 23 905 908 O
medications 24 35 909 920 B-treatment
or 36 38 921 923 O
patients 39 47 924 932 O
on 48 50 933 935 O
multiple 51 59 936 944 O
medications 60 71 945 956 O
may 72 75 957 960 O
also 76 80 961 965 O
be 81 83 966 968 O
excluded 84 92 969 977 O
according 93 102 978 987 O
to 103 105 988 990 O
investigator 106 118 991 1003 O
discretion 119 129 1004 1014 O

Subjects 0 8 1015 1023 O
previously 9 19 1024 1034 O
diagnosed 20 29 1035 1044 O
with 30 34 1045 1049 O
cardiac 35 42 1050 1057 B-chronic_disease
dysrhythmia 43 54 1058 1069 I-chronic_disease

Subjects 0 8 1070 1078 O
requiring 9 18 1079 1088 O
regular 19 26 1089 1096 O
transfusions 27 39 1097 1109 B-treatment
for 40 43 1110 1113 O
any 44 47 1114 1117 O
reason 48 54 1118 1124 O

Subjects 0 8 1125 1133 O
taking 9 15 1134 1140 O
daily 16 21 1141 1146 O
aspirin 22 29 1147 1154 B-treatment
or 30 32 1155 1157 O
other 33 38 1158 1163 O
anti 39 43 1164 1168 B-treatment
- 43 44 1168 1169 I-treatment
platelet 44 52 1169 1177 I-treatment
or 53 55 1178 1180 O
anti 56 60 1181 1185 B-treatment
- 60 61 1185 1186 I-treatment
coagulants 61 71 1186 1196 I-treatment
agents 72 78 1197 1203 I-treatment
( 79 80 1204 1205 O
Plavix 80 86 1205 1211 B-treatment
) 86 87 1211 1212 O

Subjects 0 8 1213 1221 O
taking 9 15 1222 1228 O
supplements 16 27 1229 1240 O
or 28 30 1241 1243 O
medications 31 42 1244 1255 B-treatment
that 43 47 1256 1260 O
affect 48 54 1261 1267 O
lipoproteins 55 67 1268 1280 O
for 68 71 1281 1284 O
at 72 74 1285 1287 O
least 75 80 1288 1293 O
the 81 84 1294 1297 O
past 85 89 1298 1302 B-upper_bound
six 90 93 1303 1306 I-upper_bound
weeks 94 99 1307 1312 I-upper_bound
including 100 109 1313 1322 O
fish 110 114 1323 1327 B-treatment
oil 115 118 1328 1331 I-treatment
supplements 119 130 1332 1343 I-treatment
, 130 131 1343 1344 O
bile 132 136 1345 1349 B-treatment
- 136 137 1349 1350 I-treatment
acid 137 141 1350 1354 I-treatment
sequestrants 142 154 1355 1367 I-treatment
, 154 155 1367 1368 O
plant 156 161 1369 1374 B-treatment
sterol 162 168 1375 1381 I-treatment
supplements 169 180 1382 1393 I-treatment
, 180 181 1393 1394 O
fibrates 182 190 1395 1403 B-treatment
, 190 191 1403 1404 O
statins 192 199 1405 1412 B-treatment
or 200 202 1413 1415 O
Niacin 203 209 1416 1422 B-treatment

Subjects 0 8 1423 1431 O
that 9 13 1432 1436 O
TSH 14 17 1437 1440 B-clinical_variable
levels 18 24 1441 1447 I-clinical_variable
are 25 28 1448 1451 O
greater 29 36 1452 1459 O
than1.5xULN 37 48 1460 1471 B-lower_bound

Subjects 0 8 1472 1480 O
with 9 13 1481 1485 O
any 14 17 1486 1489 O
acute 18 23 1490 1495 O
and 24 27 1496 1499 O
life 28 32 1500 1504 O
- 32 33 1504 1505 O
threatening 33 44 1505 1516 O
condition 45 54 1517 1526 O
, 54 55 1526 1527 O
such 56 60 1528 1532 O
as 61 63 1533 1535 O
prior 64 69 1536 1541 O
sudden 70 76 1542 1548 O
cardiac 77 84 1549 1556 B-chronic_disease
arrest 85 91 1557 1563 I-chronic_disease
, 91 92 1563 1564 O
acute 93 98 1565 1570 B-chronic_disease
myocardial 99 109 1571 1581 I-chronic_disease
infarction 110 120 1582 1592 I-chronic_disease
( 121 122 1593 1594 O
last 122 126 1594 1598 B-upper_bound
three 127 132 1599 1604 I-upper_bound
months 133 139 1605 1611 I-upper_bound
) 139 140 1611 1612 O
, 140 141 1612 1613 O
stroke 142 148 1614 1620 B-chronic_disease
, 148 149 1620 1621 O
embolism 150 158 1622 1630 B-chronic_disease

Subjects 0 8 1631 1639 O
with 9 13 1640 1644 O
chronic 14 21 1645 1652 B-chronic_disease
diarrhea 22 30 1653 1661 I-chronic_disease
, 30 31 1661 1662 O
gastric 32 39 1663 1670 B-treatment
bypass 40 46 1671 1677 I-treatment
or 47 49 1678 1680 O
lap 50 53 1681 1684 B-treatment
- 53 54 1684 1685 I-treatment
band 54 58 1685 1689 I-treatment
procedures 59 69 1690 1700 I-treatment
, 69 70 1700 1701 O
ostomies 71 79 1702 1710 B-treatment
, 79 80 1710 1711 O
bowel 81 86 1712 1717 B-chronic_disease
motility 87 95 1718 1726 I-chronic_disease
problems 96 104 1727 1735 I-chronic_disease
, 104 105 1735 1736 O
or 106 108 1737 1739 O
other 109 114 1740 1745 O
conditions 115 125 1746 1756 O
that 126 130 1757 1761 O
could 131 136 1762 1767 O
affect 137 143 1768 1774 O
intestinal 144 154 1775 1785 O
fat 155 158 1786 1789 O
absorption 159 169 1790 1800 O

Subjects 0 8 1801 1809 O
with 9 13 1810 1814 O
clinically 14 24 1815 1825 O
diagnosed 25 34 1826 1835 O
hepatic 35 42 1836 1843 B-chronic_disease
disease 43 50 1844 1851 I-chronic_disease
( 51 52 1852 1853 O
including 52 61 1853 1862 O
but 62 65 1863 1866 O
not 66 69 1867 1870 O
limited 70 77 1871 1878 O
to 78 80 1879 1881 O
auto 81 85 1882 1886 B-chronic_disease
immune 86 92 1887 1893 I-chronic_disease
disease 93 100 1894 1901 I-chronic_disease
, 100 101 1901 1902 O
hepatitis 102 111 1903 1912 B-chronic_disease
and 112 115 1913 1916 O
cirrhosis 116 125 1917 1926 B-chronic_disease
) 125 126 1926 1927 O

Subjects 0 8 1928 1936 O
with 9 13 1937 1941 O
known 14 19 1942 1947 O
bleeding 20 28 1948 1956 B-chronic_disease
disorders 29 38 1957 1966 I-chronic_disease
( 39 40 1967 1968 O
for 40 43 1968 1971 O
example 44 51 1972 1979 O
, 51 52 1979 1980 O
Hemophilia 53 63 1981 1991 B-chronic_disease
) 63 64 1991 1992 O

Subjects 0 8 1993 2001 O
with 9 13 2002 2006 O
weight 14 20 2007 2013 B-clinical_variable
changes 21 28 2014 2021 O
greater 29 36 2022 2029 O
than 37 41 2030 2034 O
20 42 44 2035 2037 B-lower_bound
% 44 45 2037 2038 I-lower_bound
over 46 50 2039 2043 O
the 51 54 2044 2047 O
past 55 59 2048 2052 B-upper_bound
3 60 61 2053 2054 I-upper_bound
months 62 68 2055 2061 I-upper_bound

clinical 0 8 2062 2070 O
evidence 9 17 2071 2079 O
of 18 20 2080 2082 O
hypothyroidism 21 35 2083 2097 B-chronic_disease

